ArticleCancer science2006

Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin alphav-mediated ADAM activity in hepatocellular carcinoma: a novel functional target for gefitinib.

Mitsuhiro Matsuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.